共 189 条
[31]
Chodosh J(2012)Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye Cornea 31 1299-887
[32]
Holland EJ(2007)Sjogren keratoconjunctivitis sicca treated with rituximab Cornea 26 886-968
[33]
De Paiva CS(2010)Effectiveness of rituximab treatment in primary Sjogren’s syndrome: a randomized, double-blind, placebo-controlled trial Arthritis Rheum 62 960-1392
[34]
Stevenson D(1998)Acanthamoeba keratitis: multicentre survey in England 1992–6. National Acanthamoeba Keratitis Study Group Br J Ophthalmol 82 1387-725
[35]
Tauber J(1993)A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992 Eye (Lond) 7 719-4
[36]
Reis BL(2014)The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjogren’s Syndrome BMC Musculoskelet Disord. 15 21-390
[37]
Sall K(2004)Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren’s syndrome Arthritis Rheum. 51 601-356
[38]
Stevenson OD(2011)Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjogren’s syndrome Scand J Rheumatol 40 387-210
[39]
Mundorf TK(2008)Advances in understanding and managing dry eye disease Am J Ophthalmol 146 350-7
[40]
Reis BL(2009)Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey Trans Am Ophthalmol Soc 107 205-undefined